AOTMiT: Transparency Council will evaluate drugs for breast and prostate cancer, among others

The agenda includes:

1 Prepare an opinion on the transfer of the active substance lapatinib from the drug program: B.9. "Treatment of patients with breast cancer (ICD-10: C50)" to the catalog of reimbursed drugs in chemotherapy.

2 Prepare an opinion on the transfer of the active substance cabazitaxel from the drug program: B.56. "Treatment of patients with prostate cancer (ICD-10: C61)" to the catalog of reimbursed drugs in chemotherapy.

3. preparation of an opinion on the transfer of the active substance radium-223 dichloride from the drug program: B.56. "Treatment of patients with prostate cancer (ICD-10: C61)" to the catalog of reimbursable drugs in chemotherapy.

4 Prepare an opinion on the draft health policy program of the local government unit "Health Rehabilitation and Support of Physical Activity of Residents of the Municipality of Rybno for 2024-2026".

5 Prepare an opinion on the draft health policy program of the local government unit "Health policy program for medical rehabilitation of the residents of the municipality of Elmowna for 2025-2029".

6 Prepare an opinion on the draft health policy program of the local government unit "Health policy program for medical rehabilitation of residents of the municipality of Olsztynek for 2025-2027".

7 Prepare an opinion on the draft health policy program of the local government unit "Rehabilitation program for residents of the Municipality of Gozdnica".

8. preparation of an opinion on the draft health policy program of the local government unit "Health policy program for therapeutic rehabilitation of residents of the Municipality of Kolo aged 60 and over for 2025- 2027". 9. preparation of an opinion on the draft health policy program of the local government unit "Health policy program Qźnia Health Kids for early detection of overweight and obesity among children and adolescents living in the Municipality of Torun for 2024-2028".

Source: AOTMiT